Affordable Access

Publisher Website

Non-small-cell lung cancer: molecular targeted therapy and personalized medicine – drug resistance, mechanisms, and strategies

Authors
Journal
Pharmacogenomics and Personalized Medicine
1178-7066
Publisher
Dove Medical Press
Publication Date
Identifiers
DOI: 10.2147/pgpm.s26058
Keywords
  • Review
Disciplines
  • Biology
  • Medicine

Abstract

Targeted therapies for cancer bring the hope of specific treatment, providing high efficacy and in some cases lower toxicity than conventional treatment. Although targeted therapeutics have helped immensely in the treatment of several cancers, like chronic myelogenous leukemia, colon cancer, and breast cancer, the benefit of these agents in the treatment of lung cancer remains limited, in part due to the development of drug resistance. In this review, we discuss the mechanisms of drug resistance and the current strategies used to treat lung cancer. A better understanding of these drug-resistance mechanisms could potentially benefit from the development of a more robust personalized medicine approach for the treatment of lung cancer.

There are no comments yet on this publication. Be the first to share your thoughts.